Bypassing Immune Rejection in Stem-Cell-Based Therapies

News   Aug 23, 2013

 
Bypassing Immune Rejection in Stem-Cell-Based Therapies
 
 
 

RELATED ARTICLES

Two Studies Provide Significant Hope in the Fight Against Antibiotic Resistance

News

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

READ MORE

Phenogenetic Map Created For Stem Cell Models Of Neurological Diseases

News

Researchers at The Ohio State University Wexner Medical Center have performed the first meta-analysis of all induced pluripotent stem cell models for neurological and neurodegenerative diseases, and created an atlas of how cell characteristics are linked to their genotype.

READ MORE

Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma

News

Kite’s Yescarta™ (axicabtagene ciloleucel) becomes first CAR T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE